ANI PHARMACEUTICALS, INC
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2017
Total Assets: $412.1M
Liabilities Breakdown FY2017
Total Liabilities: $237.4M
Asset Breakdown
Total Assets: $412.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $31.1M | 7.6% |
| Accounts Receivable | $58.8M | 14.3% |
| Inventory | $37.7M | 9.2% |
| Property, Plant & Equipment | $20.4M | 5.0% |
| Goodwill | $1.8M | 0.4% |
| Intangible Assets | $229.8M | 55.8% |
| Other Assets | $32.4M | 7.9% |
Liabilities Breakdown
Total Liabilities: $237.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.6M | 1.5% |
| Long-Term Debt | $69.9M | 29.5% |
| Other Liabilities | $163.8M | 69.0% |